Uncategorized
New Case Study Published: Investigating The Formulation of Cytocaf® Materials as Polymeric Inks for Bioprinting
New Case Study Published: Investigating The Formulation of Cytocaf® Materials as Polymeric Inks for Bioprinting We’re delighted to share a new case study from the Henry Royce Institute highlighting our collaboration with CPI and the Royce to develop next-generation animal-free bioinks for 3D bioprinting, funded by the Royce Industrial Collaboration Programme (ICP). The project explored…
Read MoreApplication note on Vitronectin-Cytocaf showing effect on pig iPSCs available now!
In this application note from Dragon Biotechnologies, showcasing work from our Innovate UK funded study, Dragon’s high-performance, suspension adapted piPSCs were grown for 10 passages in 3D cell culture, maintaining levels of key pluripotency markers: 99% SOX2+, 98% OCT4+, 99% SSEA4+. Crucially, when our Anticlump-Cytocaf protein was added, the aggregates remained small and uniform, with…
Read MoreMarraBio featured in BIA PULSE: Empowering the future of UK Biotech
A case study on MarraBio as part of the Bioindustry Association’s PULSE: Empowering the future of UK Biotech series. As a PULSE alumnus, Dr. Daniel Peters looks back at the development of MarraBio in the years since the PULSE programme: https://www.bioindustry.org/resource-report/pulse.html
Read MoreReview on Caf1 technology published
Want to learn more about our technology? This new review by David Fulton, Gema Dura and Daniel Peters published in Biomaterials Science explains the science behind our Caf1 material and how its unusual structural biology leads to a unique combination of useful properties. Find it here: https://pubs.rsc.org/en/content/articlehtml/2023/bm/d3bm01075a
Read MoreNewcastle University spinout secures seed investment
Pioneering life science start-up raises funding to commercialise its unique protein technology. Three North East based investment funds have combined forces with a biotech industry specialist to support Newcastle University’s latest spin out company, MarraBio Ltd (“Marrabio”). Maven Capital Partners (“Maven”), CPI Enterprises, Northstar Ventures, and TCS Biosciences have together provided MarraBio with an initial round…
Read MoreInnovate UK funding links North East biotech companies to create innovative tools for the manufacture of novel foods
MarraBio and Aelius Biotech to partner with CPI to produce food grade materials that enhance the production of lab grown meat. Newcastle, 19th December 2023: Three North East based organisations will be joining forces as a result of a successful Innovate UK grant application focused on supporting technologies for “Novel Low-Emission Food Production Systems”. The…
Read More